4.7 Article

Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients

Journal

NEUROBIOLOGY OF DISEASE
Volume 37, Issue 3, Pages 596-603

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2009.11.010

Keywords

Bipolar disorder; Apoptosis; Caspase; BDNF; Synaptophysin; Drebrin

Categories

Funding

  1. Harvard Brain Bank, Boston, MA [R24MH068855]
  2. Intramural Research Programs of the National Institute on Aging
  3. National Institute of Environmental Health Sciences, National Institutes of Health Bethesda, MD 20892

Ask authors/readers for more resources

Bipolar disorder (BD) is a progressive psychiatric disorder characterized by recurrent changes of mood and is associated with cognitive decline. There is evidence of excitotoxicity, neuroinflammation, upregulated arachidonic acid (AA) cascade signaling and brain atrophy in BD patients. These observations suggest that BD pathology may be associated with apoptosis as well as with disturbed synaptic function. To test this hypothesis, we measured mRNA and protein levels of the pro-apoptotic (Bax, BAD, caspase-9 and caspase-3) and anti-apoptotic factors (BDNF and Bcl-2) and of pre- and post-synaptic markers (synaptophysin and drebrin), in postmortem prefrontal cortex (Brodmann area 9) from 10 BD patients and 10 age-matched controls. Consistent with the hypothesis, BID brains showed significant increases in protein and mRNA levels of the pro-apoptotic factors and significant decreases of levels of the anti-apoptotic factors and the synaptic markers, synaptophysin and drebrin. These differences may contribute to brain atrophy and progressive cognitive changes in BD. (C) Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available